173 related articles for article (PubMed ID: 32634388)
1. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.
Jone PN; Korst A; Karimpour-Fard A; Thomas T; Dominguez SR; Heizer H; Anderson MS; Glode MP; Sucharov CC; Miyamoto SD
J Mol Cell Cardiol; 2020 Sep; 146():12-18. PubMed ID: 32634388
[TBL] [Abstract][Full Text] [Related]
2. The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.
Ning Q; Chen L; Song S; Zhang H; Xu K; Liu J; Zhou Y; Zang C; Li G; Chen F; Jia J; Ding G; Huang M
Biomed Res Int; 2020; 2020():9061568. PubMed ID: 32733962
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of circulating miRNAs in Kawasaki disease in China: Current evidence based on a meta-analysis.
Zheng X; Li Y; Yue P; Ma F; Zhang Y; Wu G
Medicine (Baltimore); 2021 Feb; 100(6):e24174. PubMed ID: 33578520
[TBL] [Abstract][Full Text] [Related]
4. Fifteen-minute consultation: Kawasaki disease: how to distinguish from other febrile illnesses: tricks and tips.
Kelly A; Sales K; Fenton-Jones M; Tulloh R
Arch Dis Child Educ Pract Ed; 2020 Jun; 105(3):152-156. PubMed ID: 31900257
[TBL] [Abstract][Full Text] [Related]
5. A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease.
Whitin JC; Yu TT; Ling XB; Kanegaye JT; Burns JC; Cohen HJ
PLoS One; 2016; 11(6):e0157024. PubMed ID: 27271757
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of serum circANRIL and hsa_circ_0123996 in children with Kawasaki disease.
Wu J; Zhou Q; Niu Y; Chen J; Zhu Y; Ye S; Xi Y; Wang F; Qiu H; Bu S
J Clin Lab Anal; 2019 Jun; 33(5):e22874. PubMed ID: 30843267
[TBL] [Abstract][Full Text] [Related]
8. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC
BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163
[TBL] [Abstract][Full Text] [Related]
9. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm.
Wang YF; Lian XL; Zhong JY; Su SX; Xu YF; Xie XF; Wang ZP; Li W; Zhang L; Che D; Yu L; Huang P; Jia HL; Gu XQ
IUBMB Life; 2019 Jul; 71(7):891-900. PubMed ID: 30724444
[TBL] [Abstract][Full Text] [Related]
10. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.
Ling XB; Lau K; Kanegaye JT; Pan Z; Peng S; Ji J; Liu G; Sato Y; Yu TT; Whitin JC; Schilling J; Burns JC; Cohen HJ
BMC Med; 2011 Dec; 9():130. PubMed ID: 22145762
[TBL] [Abstract][Full Text] [Related]
11. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
[TBL] [Abstract][Full Text] [Related]
12. A study of cardiovascular miRNA biomarkers for Kawasaki disease.
Rowley AH; Pink AJ; Reindel R; Innocentini N; Baker SC; Shulman ST; Kim KY
Pediatr Infect Dis J; 2014 Dec; 33(12):1296-9. PubMed ID: 25037038
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
Wright VJ; Herberg JA; Kaforou M; Shimizu C; Eleftherohorinou H; Shailes H; Barendregt AM; Menikou S; Gormley S; Berk M; Hoang LT; Tremoulet AH; Kanegaye JT; Coin LJM; Glodé MP; Hibberd M; Kuijpers TW; Hoggart CJ; Burns JC; Levin M;
JAMA Pediatr; 2018 Oct; 172(10):e182293. PubMed ID: 30083721
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Significance of miR-937 in Peripheral Blood Mononuclear Cells of Kawasaki Disease.
Wang Z; Zhou J; Dong N; Li W
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710429
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
Zhang R; Wu L; Zhang HJ; Gao XJ; Pan XT; Wang XR; Ye H; Liu GH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
[TBL] [Abstract][Full Text] [Related]
16. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.
Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y
Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160
[TBL] [Abstract][Full Text] [Related]
17. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease.
Nakaoka H; Hirono K; Yamamoto S; Takasaki I; Takahashi K; Kinoshita K; Takasaki A; Nishida N; Okabe M; Ce W; Miyao N; Saito K; Ibuki K; Ozawa S; Adachi Y; Ichida F
Sci Rep; 2018 Jan; 8(1):1016. PubMed ID: 29343815
[TBL] [Abstract][Full Text] [Related]
19. Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.
Weng KP; Cheng CF; Chien KJ; Ger LP; Huang SH; Tsai KW
Curr Issues Mol Biol; 2021 Jun; 43(2):485-500. PubMed ID: 34202375
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-184 and miR-19a-3p induces endothelial dysfunction by targeting AGO2 in Kawasaki disease.
Liao J; Guo X; Fan X; Zhang X; Xu M
Cardiol Young; 2023 Oct; 33(10):1962-1966. PubMed ID: 36424716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
